WASHINGTON, D.C. (February 11, 2021) — The U.S. Government Accountability Office (GAO) today released an online dashboard that provides an interactive view of vaccine development data. The tool has information on the vaccines that received federal funding from the Operation Warp Speed program.
“Today’s website illustrates how GAO is innovating to be more responsive to the Congress and the public,” said Gene L. Dodaro, Comptroller General of the United States and head of the GAO. “The COVID-19 vaccine landscape is constantly changing. To report on it effectively, we’re bringing more timely data to our in-depth analysis.”
GAO sent questionnaires to the vaccine companies and used their responses to independently analyze the readiness of each company’s vaccine technology. Visitors can use the dashboard to interact with technology readiness data on each of the vaccines in the program and view additional data, such as the review status for each vaccine and information about clinical trials (https://ows.gaoinnovations.gov/vaccine-tracker.)
The website also offers additional resources, including GAO’s analysis of Operation Warp Speed program funding and information from industry sources and federal agencies on vaccine manufacturing challenges. Data is pulled from a number of government websites and will be displayed as those are updated and as GAO updates its own information.
A report, also released today, accompanies the website. The report looks at how the vaccine companies accelerated and combined some steps in the development process to meet unprecedented timeframes. In addition, it describes what is being done to address manufacturing challenges. For example, agencies have worked to expedite procurement and delivery of critical manufacturing equipment.
The website and report provide Congress and the public with independently-verified, science-based information on federal efforts in COVID-19 vaccine development. As more data becomes available, GAO expects to add to the website and issue new reports on federal efforts in vaccine manufacturing, distribution, and administration.
For more information, contact Chuck Young, Managing Director of Public Affairs, at 202-512-4800.
The Government Accountability Office, known as the investigative arm of Congress, is an independent, nonpartisan agency that exists to support Congress in meeting its constitutional responsibilities. GAO also works to improve the performance of the federal government and ensure its accountability to the American people. The agency examines the use of public funds; evaluates federal programs and policies; and provides analyses, recommendations, and other assistance to help Congress make informed oversight, policy, and funding decisions. GAO provides Congress with timely information that is objective, fact-based, nonideological, fair, and balanced. GAO’s commitment to good government is reflected in its core values of accountability, integrity, and reliability.
Washington, DC (February 1, 2021)—As hundreds of billions of dollars in COVID-19 relief are distributed, FraudNet—the U.S. Government Accountability Office’s (GAO) hotline for processing allegations of fraud, waste, abuse, and mismanagement in federal programs—stands ready to receive any new complaints from the public, federal workers, and contractors about the use of funds intended to combat the impact of the coronavirus pandemic.